Agenus Inc (AGEN.PH)

AGEN.PH on Philadelphia Stock Exchange

8.76USD
1 Jul 2015
Change (% chg)

$0.13 (+1.51%)
Prev Close
$8.63
Open
$8.87
Day's High
$9.12
Day's Low
$8.43
Volume
23,075
Avg. Vol
16,092
52-wk High
$10.10
52-wk Low
$2.62

AGEN.PH

Chart for AGEN.PH

About

Agenus Inc. (Agenus) is an immunotherapy company. The Company is engaged in discovering and developing treatments for patients with cancer and other diseases. Its approaches are driven by three platform technologies: Its antibody platform, including Retrocyte Display technology, which is designed to produce human monoclonal... (more)

Overall

Beta: 1.61
Market Cap(Mil.): $724.42
Shares Outstanding(Mil.): 82.51
Dividend: --
Yield (%): --

Financials

  AGEN.PH Industry Sector
P/E (TTM): -- 440.78 39.29
EPS (TTM): -0.95 -- --
ROI: -63.69 -4.53 16.27
ROE: -110.99 -5.39 17.40
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: New Constructs, LLC
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks